Nobivac® NXT Canine-3 Rabies 
Nobivac® NXT Feline-3 Rabies

Product Description

Minimum age: 12 weeks
Volume: 0.5 mL
Administration: Subcutaneous
Duration of immunity: 3 years^†
Presentation: 25 x 1 dose

^†Label indication is 1 dose as early as 12 weeks of age, 1 booster injection a year later, then revaccinate every 3 years.

Enter the NXT era of rabies protection

With Nobivac® NXT Canine-3 Rabies and Nobivac® NXT Feline-3 Rabies, the first and only rabies vaccines for cats and dogs built on RNA particle technology.

No more than what’s necessary in every vial

0.5-mL dose. Adjuvant-free.
Preservative-free.

Multilayered immune system activation

RNA particle technology creates powerful antibody and cell-mediated immune responses.

Performance without compromise

Robust and reliable efficacy, with demonstrated safety.

UNCOVER THE SCIENCE BEHIND NOBIVAC® NXT

A first in companion animals vaccines,
a leap forward in protection.

Nobivac® NXT Canine-3 Rabies

The first Canadian advancement in rabies vaccine technology in 35 years.

View the product label

Nobivac® NXT Feline-3 Rabies

A gentle vaccine that fiercely protects.

View the product label

Always read the labels to determine whether the products are suitable for the animals to be vaccinated. Vaccination may not fully protect every animal that gets vaccinated.

Revolutionary RNA particle technology

Delivers the RNA sequence of a pathogen’s specific gene of interest (GOI) in a targeted way to the dendritic cell
The GOI is unpackaged and, for a limited time, makes multiple copies of itself
The copies of the GOI are translated into large amounts of antigen, which stimulates a broad and balanced immune response